A Novel Synthetic Adjuvant Enhances Dendritic Cell Function

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 2009 Sep 11

PMID 19740319

Citations 11

Authors

Karen S M Phillipps

Michelle N Wykes

Xue Q Liu

Melissa Brown

Joanne Blanchfield

Istvan Toth

Affiliations

Soon will be listed here.

Abstract

The lipid core peptide (LCP) is a novel, synthetic, self-adjuvanted vaccine delivery system that neatly incorporates the adjuvant, carrier and antigenic peptides of a vaccine into a single molecular entity. This system has been previously shown to efficiently deliver vaccines and induce immunity. Because adjuvants target sentinels of the immune response, such as dendritic cells (DCs), that are widely distributed throughout the body to initiate specific immune responses, we investigated the effects of the adjuvant on DCs. Here we show that LCP targets vaccines to DCs and induces their activation.

Citing Articles

T4 Phage Displaying Dual Antigen Clusters Against H3N2 Influenza Virus Infection.

Liu S, Lin M, Zhou X Vaccines (Basel). 2025; 13(1).

PMID: 39852849 PMC: 11769387. DOI: 10.3390/vaccines13010070.

Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold.

Weidenbacher P, Rodriguez-Rivera F, Sanyal M, Visser J, Do J, Bertozzi C ACS Chem Biol. 2022; 17(5):1184-1196.

PMID: 35412807 PMC: 9127789. DOI: 10.1021/acschembio.2c00140.

Lipopeptides for Vaccine Development.

Hamley I Bioconjug Chem. 2021; 32(8):1472-1490.

PMID: 34228433 PMC: 8382226. DOI: 10.1021/acs.bioconjchem.1c00258.

HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production.

Farag M, Suef R, Al-Toukhy G, Selim M, Elbahnasawy M, El Sharkawy N Infect Drug Resist. 2020; 13:2699-2709.

PMID: 32821133 PMC: 7418458. DOI: 10.2147/IDR.S265681.

The application of self-assembled nanostructures in peptide-based subunit vaccine development.

Zhao G, Chandrudu S, Skwarczynski M, Toth I Eur Polym J. 2020; 93:670-681.

PMID: 32226094 PMC: 7094324. DOI: 10.1016/j.eurpolymj.2017.02.014.

References

McLellan A, Kapp M, Eggert A, Linden C, Bommhardt U, Brocker E . Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood. 2002; 99(6):2084-93. DOI: 10.1182/blood.v99.6.2084. View

Wykes M, Pombo A, Jenkins C, MacPherson G . Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol. 1998; 161(3):1313-9. View

Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, Koh A . A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol. 2004; 172(8):4733-43. DOI: 10.4049/jimmunol.172.8.4733. View

Buwitt-Beckmann U, Heine H, Wiesmuller K, Jung G, Brock R, Akira S . Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol. 2004; 35(1):282-9. DOI: 10.1002/eji.200424955. View

Olive C, Batzloff M, Horvath A, Wong A, Clair T, Yarwood P . A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun. 2002; 70(5):2734-8. PMC: 127950. DOI: 10.1128/IAI.70.5.2734-2738.2002. View

Sandor F, Buc M . Toll-like receptors. I. Structure, function and their ligands. Folia Biol (Praha). 2005; 51(5):148-57. View

Nakao Y, Funami K, Kikkawa S, Taniguchi M, Nishiguchi M, Fukumori Y . Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J Immunol. 2005; 174(3):1566-73. DOI: 10.4049/jimmunol.174.3.1566. View

Takeda K, Takeuchi O, Akira S . Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res. 2003; 8(6):459-63. DOI: 10.1179/096805102125001073. View

Akira S, Takeda K . Toll-like receptor signalling. Nat Rev Immunol. 2004; 4(7):499-511. DOI: 10.1038/nri1391. View

10.

Dearman R, Cumberbatch M, Maxwell G, Basketter D, Kimber I . Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells. Immunology. 2008; 126(4):475-84. PMC: 2673360. DOI: 10.1111/j.1365-2567.2008.02922.x. View

11.

Hajjar A, OMahony D, Ozinsky A, Underhill D, Aderem A, Klebanoff S . Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol. 2000; 166(1):15-9. DOI: 10.4049/jimmunol.166.1.15. View

12.

Yi A, Chang M, Peckham D, Krieg A, Ashman R . CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol. 1998; 160(12):5898-906. View

13.

Zhong G, Toth I, Reid R, Brunham R . Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. J Immunol. 1993; 151(7):3728-36. View

14.

Takeda K, Kaisho T, Akira S . Toll-like receptors. Annu Rev Immunol. 2003; 21:335-76. DOI: 10.1146/annurev.immunol.21.120601.141126. View

15.

Buwitt-Beckmann U, Heine H, Wiesmuller K, Jung G, Brock R, Akira S . TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem. 2006; 281(14):9049-57. DOI: 10.1074/jbc.M512525200. View

16.

Lien E, Sellati T, Yoshimura A, Flo T, Rawadi G, Finberg R . Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem. 1999; 274(47):33419-25. DOI: 10.1074/jbc.274.47.33419. View

17.

Doxsee C, Riter T, Reiter M, Gibson S, Vasilakos J, Kedl R . The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells. J Immunol. 2003; 171(3):1156-63. DOI: 10.4049/jimmunol.171.3.1156. View

18.

Boonstra A, Rajsbaum R, Holman M, Marques R, Asselin-Paturel C, Pereira J . Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol. 2006; 177(11):7551-8. DOI: 10.4049/jimmunol.177.11.7551. View

19.

Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson N . TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol. 2005; 174(12):7558-63. DOI: 10.4049/jimmunol.174.12.7558. View

20.

Bhatia S, Edidin M, Almo S, Nathenson S . B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol Lett. 2006; 104(1-2):70-5. DOI: 10.1016/j.imlet.2005.11.019. View